Craving to Biologics Used in Severe Asthma
NCT05426538 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150
Last updated 2022-08-24
Summary
Some patients treated with biologics for severe asthma experience a craving to the next biological administration. This phenomenon has never been described before. In this study, the researchers aim to further elucidate the feeling of needing the next administration of a biologic for severe asthma.
Conditions
Sponsors & Collaborators
-
Frisius Medisch Centrum
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-12-10
- Primary Completion
- 2022-07-01
- Completion
- 2022-08-01
Countries
- Netherlands
Study Locations
More Related Trials
-
A Study to Investigate the Safety, Tolerability and Effects of AZD8630 in Healthy Subjects and Subjects With Asthma on Inhaled Corticosteroids and Long-acting Beta-agonists
NCT05110976 ·Status: COMPLETED ·Phase: PHASE1
-
Inhaler Adherence and Inhalation Technique Assessed by a Smart Spacer in Patients with Severe Asthma on Biologics
NCT06360393 ·Status: RECRUITING
-
A Study to Assess Selected Biomarkers in Subjects Requiring Daily Inhaled Corticosteroids for Persistent Asthma
NCT01334853 ·Status: COMPLETED
-
Does Inhaled Busedonide or Fluticasone Impair Adrenal Function?
NCT00560625 ·Status: TERMINATED
-
BI 671800 in Asthmatic Patients on Inhaled Corticosteroids
NCT01103349 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Biologicals on Alternative Functions of Eosinophils in Severe Asthma
NCT04520165 ·Status: ACTIVE_NOT_RECRUITING
-
A Retrospective Chart Review to Investigate Clinical Remission in Patients With Severe Asthma Treated With Biologics in the United Kingdom National Health Service
NCT06261567 ·Status: COMPLETED
-
A Study to Compare Severe Asthma Patients Who Start Biologics and Who do Not Start (PROSPECT)
NCT04808518 ·Status: COMPLETED
-
A Phase IIa Study of Subcutaneous AER 001 on Antigen Challenge In Atopic Asthmatic Subjects (28 Day Study)
NCT00535028 ·Status: COMPLETED ·Phase: PHASE2
-
Chronic Life Stress and Incident Asthma in Adult Women
NCT00006498 ·Status: COMPLETED
-
Characterisation of Patients With Severe Asthma in Primary and Secondary Care Settings in Europe Reported to be Eligible for Biological Therapy
NCT03629782 ·Status: COMPLETED
-
A Safety, Pharmacokinetic, and Pharmacodynamic Study of Once Daily Inhaled AZD8630 in Adults With Asthma
NCT06795906 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess Bronchospasm Potentially Induced by Next-Generation Propellant vs HFA Propellant in an MDI in Participants With Well/Partially Controlled Asthma
NCT05850494 ·Status: COMPLETED ·Phase: PHASE3
-
Descriptive Study of the Incidence of Malignancy in Severe Asthma Patients Receiving Benralizumab and Other Biologic Therapy, a Post Authorization Safety Study
NCT04991805 ·Status: COMPLETED
-
Study Evaluating Etanercept in Moderate to Severe Asthma
NCT00141791 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Safety, Tolerability and Effects of MEDI-563 in Adults With Asthma
NCT00659659 ·Status: COMPLETED ·Phase: PHASE1
-
Identification of Serum Biomarkers for CD15+ Hypodense Neutrophils in Severe Asthma
NCT02659618 ·Status: COMPLETED
-
Exacerbation Risk in Asthma
NCT05501639 ·Status: COMPLETED
-
Inflammatory Processes in the Airway of Asthmatics With Persistent Bronchial Hyperreactivity
NCT00217854 ·Status: COMPLETED ·Phase: NA
-
Inflammation and Corticosteroid Responsiveness in Severe Asthma
NCT00180661 ·Status: COMPLETED
-
A Long-term Study of Ba253BINEB in Patients With Bronchial Asthma
NCT02182661 ·Status: COMPLETED ·Phase: PHASE3
-
Zileuton CR vs Placebo in Poorly Controlled Asthma Patients on Moderate Dose ICS
NCT00486343 ·Status: TERMINATED ·Phase: PHASE4
-
Fluctuation Analyses of Asthma Patients With Biologics Use
NCT06024707 ·Status: NOT_YET_RECRUITING
-
Evaluate the Efficacy and Safety of FB704A in Adult With Severe Asthma
NCT05018299 ·Status: RECRUITING ·Phase: PHASE2
-
Effects of Allergen Inhalation on Adenosine Receptor Expression in Sputum and Peripheral Blood
NCT00116311 ·Status: UNKNOWN